Eli Lilly Searches For New GC As Top Atty Plans To Retire
Law360 (July 11, 2019, 5:41 PM EDT) -- Eli Lilly and Co. on Thursday announced that its senior vice president and general counsel plans to retire at the end of 2019 after 28 years with the pharmaceutical company, and a search has begun for his successor.
Mike Harrington, who for seven years has served on Eli Lilly's executive team, was credited in the announcement with helping the company hold onto patent exclusivity for medicines, including one of its best-selling cancer treatments: Alimta.
Chairman and CEO David Ricks also applauded Harrington for his assistance in finalizing the Elanco divestiture, and for acquisitions such as of Loxo Oncology Inc.
"But his impact goes...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!